The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000867392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
18/06/2026
Date registered
Help: Date registered
15/07/2026
Date last updated
Help: Date last updated
15/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
15/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Comparing absorption of protein from high-protein fermented and non-fermented foods in older adults
Scientific title
Postprandial amino acid absorption from fermented and non-fermented soy foods compared with beef in older adults: A randomised cross-over study
Additional trial identifiers [1] 317476 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
sarcopenia 342292 0
Condition category
Condition code
Musculoskeletal 338302 338302 0 0
Other muscular and skeletal disorders
Metabolic and Endocrine 338802 338802 0 0
Normal metabolism and endocrine development and function

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
What is the intervention:
• Soybeans: 71 g of raw soybeans (~180 g cooked), providing ~2 g of leucine, will be soaked overnight, boiled, and frozen in pre-weighed portions to ensure consistency across participants. On the day of testing, portions will be reheated (via microwave) to serving temperature.
• Beef: 139 g of raw beef (minced, 10% fat), providing ~2 g of leucine, will be portioned into patties and frozen before being pan-cooked fresh each test day, using standardised cooking method (dry pan, no added oil), weighed before and after cooking to track moisture loss.
• Tempeh: 143 g of raw, commercially prepared tempeh, from the company Primasoy, will be steamed for 10 minutes before serving
• Natto: 164g of raw, frozen, commercially prepared Natto (from the company Dai’s Natto) will be thawed overnight prior to the test day, stirred and served immediately.

Each meal will be provided alongside 5 mL of soy sauce that can be added optionally by the participants for flavour. Any uneaten food will be weighed to correct the ingested leucine dose.

Who delivers it and their relevant expertise: Test meals will be prepared and administered by the study team under the supervision of Chief Investigator (Senior Lecturer in Nutrition and Dietetics, La Trobe University; APD; PhD in Nutrition; expertise in whole-food protein interventions, musculoskeletal health, and clinical trial coordination). Blood sampling will be performed by a registered nurse along with experienced researchers from Swinburne and La Trobe Universities. Expertise in food safety and nutritional analysis of food products will also be delivered by APDs from Swinburne and La Trobe Universities. A PhD student will coordinate day-to-day study activities.

How it is delivered: face to face and will be in groups of a maximum of 2

How often and for how long: 4 sessions (about 6.5 Hours each- each delivering a different intervention of either soy beans, tempeh, natto and beef) and one screening visit (60 minutes) prior to commencement of the 4 sessions. Each of the 4 interventions (soy beans, tempeh, natto and beef) will only be served once. there is a washout period that will be 1 week inbetween each session.

Where it is delivered: Metabolic lab (venous blood sampling room) and food-safe kitchen at La Trobe University, Melbourne, Australia.

Adherence:
• Written study day checklist will be given at screening, covering the 2-day diet prior to the test-days, alcohol and exercise restrictions and the overnight fast.
• They will receive an email 48 hours before each visit repeating the key instructions in plain language.
• They will be provided with a standardised evening meal prior to the testing days that they are to eat prior to 10pm.
• Participants will be provided with a printed version of their 2-day diet diary after they have recorded it before the first test day, and asked to tick off each item as it is consumed for each of the 2-day periods prior to each subsequent test day.
• Verbal checklists on testing days will be used to confirm no strenuous exercise, alcohol or medication deviations.
• Test meals will be served under staff supervision, and monitored for complete consumption.
• Researchers will remind participants to complete each VAS at the allocated time points.
• Participants will remain in a comfortable lounge area throughout the testing period.
• Participants will receive a reminder card for their next visit upon completion of each visit.
• Participants will be provided with a $250 voucher upon completing the study (or a pro-rata amount depending on number of testing days completed) to reimburse them for their time and travel.
Intervention code [1] 334270 0
Lifestyle
Intervention code [2] 334608 0
Prevention
Intervention code [3] 334609 0
Treatment: Other
Description of the comparator or control
Beef is the comparator. Beef is recommended as a high-quality source of leucine and other essential amino acids that is easily digested and supports healthy muscle maintenance into older age. This serves as an example of a gold standard protein source for older adults

Who delivers it and their relevant expertise: Test meals will be prepared and administered by the study team under the supervision of Chief Investigator (Senior Lecturer in Nutrition and Dietetics, La Trobe University; APD; PhD in Nutrition; expertise in whole-food protein interventions, musculoskeletal health, and clinical trial coordination). Blood sampling will be performed by a registered nurse along with experienced researchers from Swinburne and La Trobe Universities. Expertise in food safety and nutritional analysis of food products will also be delivered by APDs from Swinburne and La Trobe Universities. A PhD student will coordinate day-to-day study activities.

How it is delivered: face to face and will be in groups of a maximum of 2

How often and for how long:4 sessions (about 6.5 Hours each- each delivering a different intervention of either soy beans, tempeh, natto and beef) and one screening visit (60 minutes) prior to commencement of the 4 sessions. Each of the 4 interventions (soy beans, tempeh, natto and beef) will only be served once. there is a washout period that will be 1 week inbetween each session.

Where it is delivered: Metabolic lab (venous blood sampling room) and food-safe kitchen at La Trobe University, Melbourne, Australia.

Adherence:
Written study day checklist will be given at screening, covering the 2-day diet prior to the test-days, alcohol and exercise restrictions and the overnight fast.
• They will receive an email 48 hours before each visit repeating the key instructions in plain language.
• They will be provided with a standardised evening meal prior to the testing days that they are to eat prior to 10pm.
• Participants will be provided with a printed version of their 2-day diet diary after they have recorded it before the first test day, and asked to tick off each item as it is consumed for each of the 2-day periods prior to each subsequent test day.
• Verbal checklists on testing days will be used to confirm no strenuous exercise, alcohol or medication deviations.
• Test meals will be served under staff supervision, and monitored for complete consumption.
• Researchers will remind participants to complete each VAS at the allocated time points.
• Participants will remain in a comfortable lounge area throughout the testing period.
• Participants will receive a reminder card for their next visit upon completion of each visit.
• Participants will be provided with a $250 voucher upon completing the study (or a pro-rata amount depending on number of testing days completed) to reimburse them for their time and travel.
Control group
Active

Outcomes
Primary outcome [1] 345642 0
Postprandial plasma leucine incremental area under the curve (iAUC) over 360 minutes, comparing boiled soybeans with lean beef.
Timepoint [1] 345642 0
0 to 360 minutes post consumption of the test meal, with baseline collected immediately prior to consumption
Secondary outcome [1] 462653 0
Postprandial plasma amino acid kinetics (0-360 minutes)
Timepoint [1] 462653 0
 0 (baseline) to 360 minutes post consumption of each test meal.
Secondary outcome [2] 462654 0
Meal palatability
Timepoint [2] 462654 0
conducted post meal consumption immediately
Secondary outcome [3] 462655 0
Gastrointestinal symptoms
Timepoint [3] 462655 0
30 minute before consumption and post consumption 30 minutes, 180 minutes and 360 minutes.

Eligibility
Key inclusion criteria
• Age is equal to 65 years and over
• BMI between 18.5 and 30 kg/m²
• Living independently in the community
• No significant recent weight change (approximately 5 percent change in body weight over the past 6 months)
• Able to understand study procedures and provide informed consent (as determined by being asked to re-explain the procedures to the research personnel during the screening visit)
• Willing to comply with fasting, meal consumption, and blood sampling requirements
• Not currently enrolled in another research study
Minimum age
65 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
• Known allergy or intolerance to soy, beef, or any component of the test meals
• Diagnosed gastrointestinal disorders (e.g. IBS, Crohn’s disease, coeliac disease)
• Diagnosed metabolic conditions (e.g. diabetes mellitus) or renal disease
• Recent history of unexplained weight loss, anaemia, or frailty (as assessed by SARC-F)
• Smoking (current)
• Blood donation within the past 2 months
• Participation in a structured or progressive resistance training program
• Regular use of medications known to affect protein metabolism (e.g. corticosteroids, NSAIDs)
• Chronic use of gastric acid suppressing medication
• Chronic use of anticoagulant medication
• Current use of immunosuppressive drugs
• Current use of medications affecting digestion or gut motility
• Resting blood pressure equals to or above 140/ 90 mmHg at screening
• Following a vegan or strict vegetarian diet

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Randomisation framework and sequences will be written down and placed inside opaque envelopes (note that the sequence will be multiplied by 2 given our target of 8 participants) before being shuffled by an individual not involved in the study.

Once shuffled, the envelopes will be numbered 1-8. After eligibility is confirmed at the screening visit by the chief investigator and the participant enrolled in the study, the next envelope in numerical order is opened and the sequence ID recorded on the case-report form. No envelopes are replaced; unused envelopes remain sealed if fewer than eight volunteers are ultimately enrolled.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomisation framework Because the trial has four interventions and uses a four-period cross-over, a canonical Williams balanced Latin square was generated, which ensures period balance and first-order carry-over balance.

Sequences will be written down and placed inside opaque envelopes (note that the sequence will be multiplied by 2 given our target of 8 participants) before being shuffled by an individual not involved in the study. Once shuffled, the envelopes will be numbered 1-8. After eligibility is confirmed at the screening visit by the chief investigator and the participant enrolled in the study, the next envelope in numerical order is opened and the sequence ID recorded on the case-report form. No envelopes are replaced; unused envelopes remain sealed if fewer than eight volunteers are ultimately enrolled.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
Sample size estimation was based on leucine iAUC values reported by Pinckaers et al., 2024 who compared postprandial plasma amino acid responses in older adults following ingestion of a whole-food omnivorous meal (containing 100 g lean ground beef) versus a whole-food vegan meal (based on soy, chickpeas, broad beans, and quinoa). Their study showed that leucine iAUC over 6 hours was significantly greater in the meat condition (15 ± 5 mmol·360 min/L) than in the plant condition (6 ± 8 mmol·360 min/L), resulting in a mean difference of 9 mmol·360 min/L. The pooled standard deviation was approximately 6.67 mmol·360 min/L, producing a large effect size (Cohen’s d approximately 1.35).
A power analysis was conducted in G*Power 3.1 using the paired samples t-test module for matched data. With an alpha of 0.05, a two-tailed test, and an effect size of 1.35, the required sample size to achieve 80 percent power is 7 participants. The planned recruitment of 8 participants allows for one dropout while retaining adequate power (actual power with 7 completers equals 84.3 percent).

1. Pinckaers, P. J., Domic, J., Petrick, H. L., Holwerda, A. M., Trommelen, J., Hendriks, F. K., Houben, L. H., Goessens, J. P., van Kranenburg, J. M., Senden, J. M., de Groot, L. C., Verdijk, L. B., Snijders, T., & van Loon, L. J. (2023). Higher Muscle Protein Synthesis Rates Following Ingestion of an Omnivorous Meal Compared with an Isocaloric and Isonitrogenous Vegan Meal in Healthy, Older Adults. The Journal of Nutrition, 154(7), 2120-2132

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 322044 0
University
Name [1] 322044 0
Department of Sport, Exercise and Nutrition Sciences, La Trobe University, Victoria, Australia.
Country [1] 322044 0
Australia
Funding source category [2] 322046 0
Commercial sector/Industry
Name [2] 322046 0
Primasoy (provision of tempeh)
Country [2] 322046 0
Australia
Funding source category [3] 322047 0
Commercial sector/Industry
Name [3] 322047 0
Dai’s Natto (provision of natto)
Country [3] 322047 0
Australia
Primary sponsor type
University
Name
La Trobe University Victoria
Address
Country
Australia
Secondary sponsor category [1] 324925 0
Commercial sector/Industry
Name [1] 324925 0
Primasoy
Address [1] 324925 0
Country [1] 324925 0
Australia
Secondary sponsor category [2] 324927 0
Commercial sector/Industry
Name [2] 324927 0
Dai's Natto
Address [2] 324927 0
Country [2] 324927 0
Australia
Other collaborator category [1] 283991 0
University
Name [1] 283991 0
Swinburne University of Technology
Address [1] 283991 0
Country [1] 283991 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320575 0
La Trobe University Human Research Ethics Committee
Ethics committee address [1] 320575 0
Ethics committee country [1] 320575 0
Australia
Date submitted for ethics approval [1] 320575 0
Approval date [1] 320575 0
23/02/2026
Ethics approval number [1] 320575 0
HEC25326

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150938 0
Dr Stephen Keenan
Address 150938 0
La Trobe University, Plenty Road, Bundoora, Vic, 3086
Country 150938 0
Australia
Phone 150938 0
+61 3 9479 3027
Fax 150938 0
Email 150938 0
Contact person for public queries
Name 150939 0
Bianca Cvetkovski
Address 150939 0
Swinburne University, John St, Hawthorn, Vic, 3122
Country 150939 0
Australia
Phone 150939 0
+61 3 9479 3027
Fax 150939 0
Email 150939 0
Contact person for scientific queries
Name 150940 0
Stephen Keenan
Address 150940 0
La Trobe University, Plenty Road, Bundoora, Vic, 3086
Country 150940 0
Australia
Phone 150940 0
+61 3 9479 3027
Fax 150940 0
Email 150940 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.